AE
Atkinson Edward Morrow III
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Atkinson Edward Morrow III. Director active across 3 companies, notably 89bio, Inc.. In total, 21 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €1.4m. Activity tracked since 1 March 2023. The latest transaction was disclosed on 24 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Atkinson Edward Morrow III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
1,627 shares@ US$485.1124.5% of flowCommon StockSEC:0000875320-26-000106:0
4,962 shares0Common StockSEC:0000875320-26-000082:0
1,903 shares@ US$487.7628.6% of flowCommon StockSEC:0000875320-26-000060:0
872 shares@ US$468.4112.6% of flowCommon StockSEC:0000875320-26-000038:0
3,934 shares0Common StockSEC:0000875320-26-000012:0
2,500 shares@ US$434.58100.0% of flowCommon StockSEC:0000875320-25-000236:0
2,482 shares@ US$479.6114.0% of flowCommon StockSEC:0000875320-25-000127:0
1,656 shares@ US$483.289.5% of flowCommon StockSEC:0000875320-25-000107:0
1,529 shares@ US$463.468.4% of flowCommon StockSEC:0000875320-25-000083:0
6,211 shares0Common StockSEC:0000875320-25-000061:0
876 shares@ US$467.984.9% of flowCommon StockSEC:0000875320-25-000037:0
5,132 shares0Common StockSEC:0000875320-25-000011:0
6,824 shares@ US$481.9637.9% of flowCommon StockSEC:0000875320-24-000174:0
14,112 shares0Common StockSEC:0000875320-24-000144:0
1,654 shares@ US$431.798.2% of flowCommon StockSEC:0000875320-24-000101:0
1,201 shares@ US$421.775.8% of flowCommon StockSEC:0000875320-24-000089:0
1,501 shares@ US$424.017.3% of flowCommon StockSEC:0000875320-24-000070:0
832 shares@ US$422.744.0% of flowCommon StockSEC:0000875320-24-000045:0
2,326 shares0Common StockSEC:0000875320-24-000020:0
6,250 shares@ US$2.6126.5% of flowCommon StockSEC:0000950170-23-026422:0
10,000 shares@ US$4.4473.5% of flowCommon StockSEC:0000899243-23-007032:0
About Atkinson Edward Morrow III
Atkinson Edward Morrow III is a declarant linked to Vertex Pharmaceuticals INC / MA and VERTEX PHARMACEUTICALS INC / MA as EVP, Chief Technical Ops. Off., and to 89bio, Inc. as Director. Across 21 filings in total, the most recent sampled filings, from 2023-03-03 to 2026-02-26, show 0 in purchases and 1403811 in sales, with Retenue fiscale as the dominant transaction nature.